Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol for Sub-Study of the ASCOT Trial
  • Published:

Protocol for Sub-study of the ASCOT Trial

Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jönsson B Measurement of health outcome and associated costs in cardiovascular disease Eur Heart J 1997 17 (Suppl) 2–7

    Google Scholar 

  2. Jönsson B Cost-benefit of treating hypertension J Hypertens 1994 12 (Suppl 10) 65–70

    Google Scholar 

  3. Weinstein M, Stason WB Allocation of resources to manage hypertension N Engl J Med 1977 296 732–739

    Article  Google Scholar 

  4. Johannesson M et alCost-effectiveness of treating hypertension in the elderly: an analysis of the Swedish Trial in Old Patients with Hypertension (STOP-hypertension) J Int Med 1993 234 317–323

    Article  CAS  Google Scholar 

  5. SBU—The Swedish Council on Technology Assessment in Health Care Moderately elevated blood pressure J Int Med 1995 238 (Suppl 737) 103–115

    Google Scholar 

  6. Jönsson B et alCost-effectiveness of cholesterol lowering, the results from the Scandinavian Simvastatin Survival Study (4S) Eur Heart J 1996 17 1001–1007

    Article  Google Scholar 

  7. Johannesson M, Meltzer D, O’Conor RM Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of treatment of hypertension Med Dec Making 1997 17 382–389

    Article  CAS  Google Scholar 

  8. Johannesson M et alCost-effectiveness of simvastatin treatment to lower cholesterol levels inpatients with coronary heart disease N Engl J Med 1997 336 332–336

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to B Jönsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jönsson, B., Buxton, M., Hertzman, P. et al. Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Hum Hypertens 15 (Suppl 1), S53–S56 (2001). https://doi.org/10.1038/sj.jhh.1001086

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001086

Keywords

This article is cited by

Search

Quick links